These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29755323)

  • 1. Environmental Enrichment Prevents Transcriptional Disturbances Induced by Alpha-Synuclein Overexpression.
    Wassouf Z; Hentrich T; Samer S; Rotermund C; Kahle PJ; Ehrlich I; Riess O; Casadei N; Schulze-Hentrich JM
    Front Cell Neurosci; 2018; 12():112. PubMed ID: 29755323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein at the nexus of genes and environment: the impact of environmental enrichment and stress on brain health and disease.
    Wassouf Z; Schulze-Hentrich JM
    J Neurochem; 2019 Sep; 150(5):591-604. PubMed ID: 31165472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
    Schaffner SL; Wassouf Z; Hentrich T; Nuesch-Germano M; Kobor MS; Schulze-Hentrich JM
    Neurobiol Dis; 2023 Oct; 186():106274. PubMed ID: 37648037
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hentrich T; Wassouf Z; Riess O; Schulze-Hentrich JM
    Aging (Albany NY); 2018 Dec; 10(12):4024-4041. PubMed ID: 30543522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
    Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
    Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Stress Response and Altered Striatal Transcriptome in Alpha-Synuclein Overexpressing Mice.
    Wassouf Z; Hentrich T; Casadei N; Jaumann M; Knipper M; Riess O; Schulze-Hentrich JM
    Front Neurosci; 2018; 12():1033. PubMed ID: 30686992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson's Disease.
    Singh Y; El-Hadidi M; Admard J; Wassouf Z; Schulze-Hentrich JM; Kohlhofer U; Quintanilla-Martinez L; Huson D; Riess O; Casadei N
    Front Neurosci; 2019; 13():1032. PubMed ID: 31749671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington's disease.
    Mo C; Hannan AJ; Renoir T
    Neurosci Biobehav Rev; 2015 May; 52():178-92. PubMed ID: 25770041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.
    Gerstenberger J; Bauer A; Helmschrodt C; Richter A; Richter F
    Behav Brain Res; 2016 May; 304():102-10. PubMed ID: 26880341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein.
    Höllerhage M; Stepath M; Kohl M; Pfeiffer K; Chua OWH; Duan L; Hopfner F; Eisenacher M; Marcus K; Höglinger GU
    Front Neurol; 2022; 13():787059. PubMed ID: 35481270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA and proteome expression profiling in early-symptomatic α-synuclein(A30P)-transgenic mice.
    Gillardon F; Mack M; Rist W; Schnack C; Lenter M; Hildebrandt T; Hengerer B
    Proteomics Clin Appl; 2008 May; 2(5):697-705. PubMed ID: 21136867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early defects in translation elongation factor 1α levels at excitatory synapses in α-synucleinopathy.
    Blumenstock S; Angelo MF; Peters F; Dorostkar MM; Ruf VC; Luckner M; Crux S; Slapakova L; Arzberger T; Claverol S; Herzog E; Herms J
    Acta Neuropathol; 2019 Dec; 138(6):971-986. PubMed ID: 31451907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology.
    Herring A; Ambrée O; Tomm M; Habermann H; Sachser N; Paulus W; Keyvani K
    Exp Neurol; 2009 Mar; 216(1):184-92. PubMed ID: 19118549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis of α-synuclein knockdown after T3 spinal cord injury in rats.
    Zeng H; Yu BF; Liu N; Yang YY; Xing HY; Liu XX; Zhou MW
    BMC Genomics; 2019 Nov; 20(1):851. PubMed ID: 31726970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.